CMS takes second run at lower reimbursement for 340B drugs
· mari serebrov
AI Briefing
- • CMS proposes updating Medicare payment rates for 340B drugs to reflect actual hospital costs.
- • The plan aims to reduce reimbursement for lower-cost outpatient drugs.
- • The proposal resurrects a rule struck down by the US Supreme Court in 2021.
Context
CMS is proposing to update Medicare payment rates for 340B drugs to reflect the actual cost of outpatient drugs to hospitals. The proposal aims to adjust reimbursement rates for drugs purchased under the 340B prescription drug discount program.
The proposal matters because it affects how hospitals are reimbursed for certain medications, specifically those bought at discounted rates through the 340B program.
Advertisement